__NUXT_JSONP__("/drugs/Epitinib_Succinate", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"The succinate salt form of epitinib, an orally available epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon administration, epitinib inhibits the activity of EGFR, thereby preventing EGFR-mediated signaling. This may lead to induction of cell death and inhibition of tumor growth in EGFR-overexpressing tumor cells. EGFR is a receptor tyrosine kinase (RTK) that is overexpressed in certain tumor types and plays a key role in tumor cell proliferation and vascularization.",fdaUniiCode:"2138WW3F3R",identifier:"C153095",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C2167"],synonyms:["EPITINIB SUCCINATE",c,"HMPL 813","HMPL-813","HMPL813"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEpitinib_Succinate",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Epitinib_Succinate","Epitinib Succinate","2021-10-30T13:33:58.863Z")));